U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

PRETEXT II Hepatoblastoma

MedGen UID:
233822
•Concept ID:
C1335256
•
Neoplastic Process
Synonyms: PRETEXT Stage 2 Hepatoblastoma; PRETEXT Stage II Hepatoblastoma

Definition

An internationally developed presurgical anatomic staging system using imaging techniques: Tumor involves 2 adjoining quadrants; 2 adjoining quadrants are free of tumor. (from PDQ 2004) [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVPRETEXT II Hepatoblastoma

Professional guidelines

PubMed

The Role Of Surgical Treatment In The Multidisciplinary Therapy For Hepatoblastoma.
Yada K, Ishibashi H, Mori H, Sato H, Shimada M
Hepatogastroenterology 2014 May;61(131):553-6. PMID: 26176034
Efficacy of preoperative transcatheter arterial chemoembolization combined with systemic chemotherapy for treatment of unresectable hepatoblastoma in children.
Hirakawa M, Nishie A, Asayama Y, Fujita N, Ishigami K, Tajiri T, Taguchi T, Honda H
Jpn J Radiol 2014 Sep;32(9):529-36. Epub 2014 Jun 13 doi: 10.1007/s11604-014-0340-y. PMID: 24923584
Guidelines for surgical treatment of hepatoblastoma in the modern era--recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL).
Czauderna P, Otte JB, Aronson DC, Gauthier F, Mackinlay G, Roebuck D, Plaschkes J, Perilongo G; Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL)
Eur J Cancer 2005 May;41(7):1031-6. doi: 10.1016/j.ejca.2005.02.004. PMID: 15862752

Recent clinical studies

Etiology

Role of Diffusion Weighted MRI (DW-MR) in Detection of Satellite Lesions Not Detected with Multiphase CT Scans in Hepatoblastoma and Its Implications for Management.
Sharma K, Agarwala S, Kandasamy D, Jana M, Sharma R, Dhua A, Jain V, Bhatnagar V
Indian J Pediatr 2022 Oct;89(10):968-974. Epub 2022 Jan 8 doi: 10.1007/s12098-021-04016-9. PMID: 34997528
Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: Analysis of the JPLT3-H pilot study.
Watanabe K, Mori M, Hishiki T, Yokoi A, Ida K, Yano M, Fujimura J, Nogami Y, Iehara T, Hoshino K, Inoue T, Tanaka Y, Miyazaki O, Takimoto T, Yoshimura K, Hiyama E
Pediatr Blood Cancer 2022 Feb;69(2):e29389. Epub 2021 Oct 4 doi: 10.1002/pbc.29389. PMID: 34606680
Tumor rupture in hepatoblastoma: A high risk factor?
Pondrom M, Pariente D, Mallon B, Taque S, Branchereau S, Chardot C, Laithier V, Tabone MD, Lejeune J, Faure-Conter C, Saumet L, Vérité C, Aerts I, Brugières L, Fresneau B
Pediatr Blood Cancer 2020 Sep;67(9):e28549. Epub 2020 Jul 3 doi: 10.1002/pbc.28549. PMID: 32618436
Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
Sunil BJ, Palaniappan R, Venkitaraman B, Ranganathan R
J Gastrointest Cancer 2018 Dec;49(4):493-496. doi: 10.1007/s12029-017-0005-z. PMID: 28963691
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P
Lancet Oncol 2017 Jan;18(1):122-131. Epub 2016 Nov 22 doi: 10.1016/S1470-2045(16)30598-8. PMID: 27884679Free PMC Article

Diagnosis

Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: Analysis of the JPLT3-H pilot study.
Watanabe K, Mori M, Hishiki T, Yokoi A, Ida K, Yano M, Fujimura J, Nogami Y, Iehara T, Hoshino K, Inoue T, Tanaka Y, Miyazaki O, Takimoto T, Yoshimura K, Hiyama E
Pediatr Blood Cancer 2022 Feb;69(2):e29389. Epub 2021 Oct 4 doi: 10.1002/pbc.29389. PMID: 34606680
Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.
Uchida H, Sakamoto S, Sasaki K, Takeda M, Hirata Y, Fukuda A, Hishiki T, Irie R, Nakazawa A, Miyazaki O, Nosaka S, Kasahara M
Pediatr Blood Cancer 2018 Dec;65(12):e27383. Epub 2018 Aug 7 doi: 10.1002/pbc.27383. PMID: 30084209
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P
Lancet Oncol 2017 Jan;18(1):122-131. Epub 2016 Nov 22 doi: 10.1016/S1470-2045(16)30598-8. PMID: 27884679Free PMC Article
Surgical strategies for unresectable hepatoblastomas.
Tajiri T, Kimura O, Fumino S, Furukawa T, Iehara T, Souzaki R, Kinoshita Y, Koga Y, Suminoe A, Hara T, Kohashi K, Oda Y, Hishiki T, Hosoi H, Hiyama E, Taguchi T
J Pediatr Surg 2012 Dec;47(12):2194-8. doi: 10.1016/j.jpedsurg.2012.09.006. PMID: 23217875
Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.
Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH
Pediatr Blood Cancer 2009 Dec;53(6):1016-22. doi: 10.1002/pbc.22088. PMID: 19588519Free PMC Article

Therapy

Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: Analysis of the JPLT3-H pilot study.
Watanabe K, Mori M, Hishiki T, Yokoi A, Ida K, Yano M, Fujimura J, Nogami Y, Iehara T, Hoshino K, Inoue T, Tanaka Y, Miyazaki O, Takimoto T, Yoshimura K, Hiyama E
Pediatr Blood Cancer 2022 Feb;69(2):e29389. Epub 2021 Oct 4 doi: 10.1002/pbc.29389. PMID: 34606680
Tumor rupture in hepatoblastoma: A high risk factor?
Pondrom M, Pariente D, Mallon B, Taque S, Branchereau S, Chardot C, Laithier V, Tabone MD, Lejeune J, Faure-Conter C, Saumet L, Vérité C, Aerts I, Brugières L, Fresneau B
Pediatr Blood Cancer 2020 Sep;67(9):e28549. Epub 2020 Jul 3 doi: 10.1002/pbc.28549. PMID: 32618436
Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
Sunil BJ, Palaniappan R, Venkitaraman B, Ranganathan R
J Gastrointest Cancer 2018 Dec;49(4):493-496. doi: 10.1007/s12029-017-0005-z. PMID: 28963691
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P
Lancet Oncol 2017 Jan;18(1):122-131. Epub 2016 Nov 22 doi: 10.1016/S1470-2045(16)30598-8. PMID: 27884679Free PMC Article
Efficacy of neoadjuvant therapy and surgical rescue for locally advanced hepatoblastomas: 10 year single-center experience and literature review.
Ayllon Teran D, Gómez Beltran O, Ciria Bru R, Mateos González E, Peña Rosa MJ, Luque Molina A, López Cillero P, Briceño Delgado J
World J Gastroenterol 2014 Aug 7;20(29):10137-43. doi: 10.3748/wjg.v20.i29.10137. PMID: 25110441Free PMC Article

Prognosis

Role of Diffusion Weighted MRI (DW-MR) in Detection of Satellite Lesions Not Detected with Multiphase CT Scans in Hepatoblastoma and Its Implications for Management.
Sharma K, Agarwala S, Kandasamy D, Jana M, Sharma R, Dhua A, Jain V, Bhatnagar V
Indian J Pediatr 2022 Oct;89(10):968-974. Epub 2022 Jan 8 doi: 10.1007/s12098-021-04016-9. PMID: 34997528
Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: Experience from the Society of Pediatric Liver Transplantation (SPLIT).
Boster JM, Superina R, Mazariegos GV, Tiao GM, Roach JP, Lovell MA, Greffe BS, Yanni G, Leung DH, Elisofon SA, McDiarmid SV, Gupta NA, Lobritto SJ, Lemoine C, Stoll JM, Vitola BE, Daniel JF, Sayed BA, Desai DM, Martin AE, Amin A, Anand R, Anderson SG, Sundaram SS
Am J Transplant 2022 May;22(5):1396-1408. Epub 2022 Jan 22 doi: 10.1111/ajt.16945. PMID: 34990053
Tumor rupture in hepatoblastoma: A high risk factor?
Pondrom M, Pariente D, Mallon B, Taque S, Branchereau S, Chardot C, Laithier V, Tabone MD, Lejeune J, Faure-Conter C, Saumet L, Vérité C, Aerts I, Brugières L, Fresneau B
Pediatr Blood Cancer 2020 Sep;67(9):e28549. Epub 2020 Jul 3 doi: 10.1002/pbc.28549. PMID: 32618436
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P
Lancet Oncol 2017 Jan;18(1):122-131. Epub 2016 Nov 22 doi: 10.1016/S1470-2045(16)30598-8. PMID: 27884679Free PMC Article
Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.
Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH
Pediatr Blood Cancer 2009 Dec;53(6):1016-22. doi: 10.1002/pbc.22088. PMID: 19588519Free PMC Article

Clinical prediction guides

Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: Experience from the Society of Pediatric Liver Transplantation (SPLIT).
Boster JM, Superina R, Mazariegos GV, Tiao GM, Roach JP, Lovell MA, Greffe BS, Yanni G, Leung DH, Elisofon SA, McDiarmid SV, Gupta NA, Lobritto SJ, Lemoine C, Stoll JM, Vitola BE, Daniel JF, Sayed BA, Desai DM, Martin AE, Amin A, Anand R, Anderson SG, Sundaram SS
Am J Transplant 2022 May;22(5):1396-1408. Epub 2022 Jan 22 doi: 10.1111/ajt.16945. PMID: 34990053
Tumor rupture in hepatoblastoma: A high risk factor?
Pondrom M, Pariente D, Mallon B, Taque S, Branchereau S, Chardot C, Laithier V, Tabone MD, Lejeune J, Faure-Conter C, Saumet L, Vérité C, Aerts I, Brugières L, Fresneau B
Pediatr Blood Cancer 2020 Sep;67(9):e28549. Epub 2020 Jul 3 doi: 10.1002/pbc.28549. PMID: 32618436
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P
Lancet Oncol 2017 Jan;18(1):122-131. Epub 2016 Nov 22 doi: 10.1016/S1470-2045(16)30598-8. PMID: 27884679Free PMC Article
PRETEXT II-III multifocal hepatoblastoma: significance of resection of satellite lesions irrespective of their disappearance after chemotherapy.
Qureshi SS, Bhagat M, Kembhavi S, Vora T, Ramadwar M, Talole S
Pediatr Surg Int 2015 Jun;31(6):573-9. Epub 2015 Apr 23 doi: 10.1007/s00383-015-3713-0. PMID: 25904441
Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.
Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH
Pediatr Blood Cancer 2009 Dec;53(6):1016-22. doi: 10.1002/pbc.22088. PMID: 19588519Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...